These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2986401)

  • 1. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.
    Uttley WS; Atkinson B; Adams A; Shirling D
    J Inherit Metab Dis; 1978; 1(2):75-7. PubMed ID: 229343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial cases of congenital nephrogenic diabetes insipidus type II: Remarkable increment of urinary adenosine 3',5'-monophosphate in response to antidiuretic hormone.
    Ohzeki T; Igarashi T; Okamoto A
    J Pediatr; 1984 Apr; 104(4):593-5. PubMed ID: 6323666
    [No Abstract]   [Full Text] [Related]  

  • 5. 1-deamino-8-D-arginine vasopressin in the treatment of central diabetes insipidus in childhood.
    Becker DJ; Foley TP
    J Pediatr; 1978 Jun; 92(6):1011-5. PubMed ID: 660339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic and PGE2 responses to AVP and dDAVP in subjects with central and nephrogenic diabetes insipidus.
    Moses AM; Scheinman SJ; Schroeder ET
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F354-9. PubMed ID: 3856399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary cyclic adenosine monophosphate excretion in diabetes insipidus of childhood. Effect of vasopressin and chlorpropamide.
    Raij K; Perheentupa J; Härkönen M
    Scand J Clin Lab Invest; 1974 Oct; 34(2):177-84. PubMed ID: 4370673
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.
    Moses AM; Coulson R
    Endocrinology; 1980 Mar; 106(3):967-72. PubMed ID: 6243558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of renal prostaglandins during antidiuresis and water diuresis in man.
    Walker RM; Brown RS; Stoff JS
    Kidney Int; 1982 Feb; 21(2):365-70. PubMed ID: 6951096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of familial central diabetes insipidus: the response of urinary prostaglandins to 1-deamino-8-D-arginine vasopressin.
    Sasaki Y; Higashihara E; Takeuchi T; Nutahara K; Homma Y; Aso Y
    J Urol; 1994 Jul; 152(1):161-3. PubMed ID: 8201652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiuretic action of oxytocin is associated with increased urinary excretion of aquaporin-2.
    Joo KW; Jeon US; Kim GH; Park J; Oh YK; Kim YS; Ahn C; Kim S; Kim SY; Lee JS; Han JS
    Nephrol Dial Transplant; 2004 Oct; 19(10):2480-6. PubMed ID: 15280526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.
    Bardoux P; Bichet DG; Martin H; Gallois Y; Marre M; Arthus MF; Lonergan M; Ruel N; Bouby N; Bankir L
    Nephrol Dial Transplant; 2003 Mar; 18(3):497-506. PubMed ID: 12584270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and hormone-induced urinary cyclic AMP in children with renal disorders.
    Monn E; Osnes JB; Oye I
    Acta Paediatr Scand; 1976 Nov; 65(6):739-45. PubMed ID: 187004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.
    Wilting I; Baumgarten R; Movig KL; van Laarhoven J; Apperloo AJ; Nolen WA; Heerdink ER; Knoers NV; Egberts AC
    Eur J Pharmacol; 2007 Jul; 566(1-3):50-7. PubMed ID: 17466972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
    Bichet DG; Razi M; Arthus MF; Lonergan M; Tittley P; Smiley RK; Rock G; Hirsch DJ
    Kidney Int; 1989 Nov; 36(5):859-66. PubMed ID: 2559238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.